Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07676474 · ClinicalTrials.gov registry record
Continuous Wireless Ultrasound to Monitor Fetal Health
A clinical trial, sponsored by Boston Children's Hospital.
- Not yet
- Registry status
- 50
- Enrollment target
NCT07676474: Clinical Trial study, sponsored by Boston Children's Hospital.
NCT07676474 is a clinical trial that has not yet begun recruiting, run by Boston Children's Hospital. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07676474 has not yet begun recruiting, sponsored by Boston Children's Hospital.
- NOT YET RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
This study is a single-center, prospective, and non-randomized feasibility study designed to evaluate the practicality, tolerability, and data quality of short-duration continuous fetal monitoring using a wireless bioadhesive ultrasound device. The study involves a single visit per participant and does not include any therapeutic intervention. Eligible participants will undergo placement of a wireless bioadhesive ultrasound (ABAUS) device on the maternal abdomen for a short-duration monitoring session. The device will acquire continuous or semi-continuous ultrasound data for a total of 10-30 minutes per participant, without altering standard clinical care. The study is observational and is intended to assess the technical feasibility of device placement, the stability of the coupling during routine maternal movement, image quality over time, and the ability to monitor fetal motion, heart rate, and uterine activity using the investigational device under controlled yet realistic clinical conditions. The study is non-interventional. No diagnostic or therapeutic decisions will be made based on the ultrasound data collected as part of this research protocol, and all standard prenatal care will proceed independently of participation in this study.
Primary Outcome
Acquisition of fetal ultrasound imaging data over a 10-30 minute period
Interventions
- DEVICE Wireless Ultrasound Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-06-30 |
| Est. Completion | 2028-06-30 |
What is known before NCT07676474 opens enrollment
NCT07676474 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Wireless Ultrasound Device is the first listed.
NCT07676474 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07676474 about?
NCT07676474 is a clinical study titled "Continuous Wireless Ultrasound to Monitor Fetal Health". This study is a single-center, prospective, and non-randomized feasibility study designed to evaluate the practicality, tolerability, and data quality of short-duration continuous fetal monitoring using a wireless bioadhesive ultrasound device. The study involves a single visit per participant and d...
What is the current status of trial NCT07676474?
This trial is currently not yet recruiting. The enrollment target is 50 participants. The study started on 2026-06-30. Estimated completion is 2028-06-30.
What interventions are being tested in trial NCT07676474?
The interventions under investigation include: Wireless Ultrasound Device (DEVICE).
Who is sponsoring clinical trial NCT07676474?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI